The DOI matches its Crossref record; 33 of the 37 references it cites were found in a registry or an index.
A Specific Inhibitor of TGF-β Receptor Kinase, SB-431542, as a Potent Antitumor Agent for Human Cancers
Open accessAbstract
Small molecule inhibitors of signaling pathways have proven to be extremely useful for the development of therapeutic strategies for human cancers. Blocking the tumor-promoting effects of transforming growth factor-beta (TGF-beta) in advanced stage carcinogenesis provides a potentially interesting drug target for therapeutic intervention. Although very few TGF-beta receptor kinase inhibitors (TRKI) are now emerging in preclinical studies, nothing is known about how these inhibitors might regulate the tumor-suppressive or tumor-promoting effects of TGF-beta, or when these inhibitors might be useful for treatment during cancer progression. We have investigated the potential of TRKI in new therapeutic approaches in preclinical models. Here, we demonstrate that the TRKI, SB-431542, inhibits TGF-beta-induced transcription, gene expression, apoptosis, and growth suppression. We have observed that SB-431542 attenuates the tumor-promoting effects of TGF-beta, including TGF-beta-induced EMT, cell motility, migration and invasion, and vascular endothelial growth factor secretion in human cancer cell lines. Interestingly, SB-431542 induces anchorage independent growth of cells that are growth-inhibited by TGF-beta, whereas it reduces colony formation by cells that are growth-promoted by TGF-beta. However, SB-431542 has no effect on a cell line that failed to respond to TGF-beta. This represents a novel potential application of these inhibitors as therapeutic agents for human cancers with the goal of blocking tumor invasion, angiogenesis, and metastasis, when tumors are refractory to TGF-beta-induced tumor-suppressor functions but responsive to tumor-promoting effects of TGF-beta.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“JSH-23 and SB-431542 can suppress NF-κB and TGF-β1/Smad3 signaling pathways respectively and thus might inhibit platelet aggregation in endometriosis91,92.”
From Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells (2020) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,571
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,697
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Transcriptional control by the TGF‐β/Smad signaling system
Massagué, J., & Wotton, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,990
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,636
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1208 · Cited by 1,626
Bhowmick, N., Ghiassi, M., Bakin, A. V., Aakre, M., Lundquist, C., Engel, M., Arteaga, C., & Moses, H. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.27 · Cited by 1,087
Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
Ashcroft, G. S., Yang, X., Glick, A. B., Weinstein, M., Letterio, J. J., Mizel, D. E., Anzano, M., Greenwell-Wild, T., Wahl, S. M., Deng, C., et al. (1999) · Nature Cell Biology · doi:10.1038/12971 · Cited by 911
TGF-β signaling: positive and negative effects on tumorigenesis
Wakefield, L. M. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00259-3 · Cited by 827
Flagged first, then by citations
4 of the 37 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–290 of 290
Xu, M.-Z., Cui, Q., Su, W., Zhang, D., Pan, J., Liu, X., Pang, Z., & Zhu, Q. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10238 · Cited by 9
A novel approach for monitoring TGF-β signaling in vivo in colon cancer
Zhang, B., Wang, C., Dong, W., Chen, X., Leng, C., Luo, X., Dong, S., Yin, P., Zhang, B., Datta, P. K., et al. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa142 · Cited by 9
Self-citationGupta, S., Sharma, P., Chaudhary, M., Premraj, S., Kaur, S. J., Vijayan, V., Arun, M. G., Prasad, N. G., & Ramachandran, R. (2022) · Glia · doi:10.1002/glia.24270 · Cited by 9
Integrin β8 Signaling in Neonatal Hypoxic–Ischemic Brain Injury
Zhang, L., Qu, Y., Tang, B., Zhao, F., Xiong, T., Ferriero, D. M., & Mu, D. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9312-0 · Cited by 9
Kamlund, S., Janicke, B., Alm, K., Judson‐Torres, R. L., & Oredsson, S. (2020) · Applied Sciences · doi:10.3390/app10144726 · Cited by 8
Mężyk-Kopeć, R., Potin, L., Medellin, J. E. G., Salles, C. M., & Swartz, M. A. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200216 · Cited by 8
Sun, X., Kim, Y., Phan, T.-N., & Yang, B.-S. (2014) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2014.932666 · Cited by 8
Transforming Growth Factor β Signaling Overcomes Dasatinib Resistance in Lung Cancer
Gordián, E. R., Li, J., Pevzner, Y., Mediavilla-Varela, M., Luddy, K. A., Ohaegbulam, K. C., Daniel, K. G., Haura, E. B., & Muñoz-Antonia, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114131 · Cited by 8
UV Light–inactivated HSV-1 Stimulates Natural Killer Cell–induced Killing of Prostate Cancer Cells
Samudio, I. J., Hofs, E., Cho, B., Li, M. Y., Bolduc, K., Bu, L., Liu, G., Lam, V., Rennie, P. S., Jia, W. W.-G., et al. (2019) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000261 · Cited by 9
Bendinelli, P., Maroni, P., Dall’Olio, V., Matteucci, E., & Desiderio, M. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102520 · Cited by 8
Kang, H., & Shyr, C. (2011) · Vitamins and hormones · doi:10.1016/b978-0-12-385961-7.00007-x · Cited by 8
Löbler, M., Buß, D., Kästner, C., Mostertz, J., Homuth, G., Ernst, M., Guthoff, R. F., Wree, A., Stahnke, T., Fuellen, G., et al. (2013) · Europe PMC (PubMed Central) · Cited by 8
Moving on: Molecular mechanisms in TGFβ‐induced epithelial cell migration
Giehl, K., & Menke, A. (2006) · Signal Transduction · doi:10.1002/sita.200600094 · Cited by 8
Hippee, C. E., Durnell, L. A., Kaufman, J. W., Murray, E., Singh, B. K., & Sinn, P. L. (2025) · Journal of Virology · doi:10.1128/jvi.01220-24 · Cited by 7
Zebrafish xenografts in breast cancer research
Rong, X., Chen, H., Guo, X., Sun, X., Li, L., Ye, Y., Li, C., Nian, S., Liang, C., & Yuan, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1540610 · Cited by 8
Aripova, N., Duryee, M. J., Zhou, W., England, B. R., Hunter, C. D., Klingemann, L. E., Aripova, N., Nelson, A. J., Katafiasz, D. M., Bailey, K. L., et al. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00153.2024 · Cited by 7
SMAD5 as a novel gene for familial pulmonary arterial hypertension
Cao, D., Grünig, E., Sirenko, Y., Radchenko, G., Gall, H. J., Ahmed, A., Theiß, S., Lankeit, M., Meder, B., Laugsch, M., et al. (2024) · Clinical Science · doi:10.1042/cs20241340 · Cited by 7
Han, J.-H., Hwang, A.-R., Nam, D.-H., Kim, S., Choi, H. C., Lim, J. H., & Woo, C.-H. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.05.006 · Cited by 7
Wang, F., Stappenbeck, F., & Parhami, F. (2023) · Pharmaceuticals · doi:10.3390/ph16010114 · Cited by 6
Das, S., Becker, B. N., Hoffmann, F. M., & Mertz, J. E. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s28 · Cited by 6
Inhibition of the TGF-β Signaling Pathway in Tumor Cells
Podar, K., Raje, N. S., & Anderson, K. C. (2007) · Springer eBooks · doi:10.1007/978-3-540-31209-3_6 · Cited by 5
Niekamp, P., Gu, D., Jiang, J., Woods, E. J., & Johnstone, B. H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1725191 · Cited by 5
Zheng, X., Wang, W., Chen, S., Zuo, B., & Li, J. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2023.01.004 · Cited by 6
Anh, L. P. H., Nishimura, K., Kuno, A., Linh, N. T., Kato, T., Ohtaka, M., Nakanishi, M., Sugihara, E., Sato, T., Hayashi, Y., et al. (2022) · Stem Cells · doi:10.1093/stmcls/sxac012 · Cited by 5
McLean, S., & Guglielmo, G. M. D. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-397925-4.00003-1 · Cited by 5
Suh, D. H., Lee, S., Park, H.-S., & Park, N. H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113585 · Cited by 5
Kushwaha, P. P., Kumar, A., Maurya, S., Singh, A. K., Sharma, A. K., & Kumar, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-6920-9_26 · Cited by 5
Bone Morphogenetic Protein Signaling: Implications in Urology
Jeong, J., Kang, D. I., Lee, G. T., & Kim, I. Y. (2010) · Korean journal of urology · doi:10.4111/kju.2010.51.8.511 · Cited by 5
Sadeghzadeh, S., Askari, R. E., Zareiye, A., Meshkin, A., Aghabozorgi, R., Lotfi, M., Ghanbari, F., Shahcheraghi, S. H., & Aghili, Z. S. (2025) · Brain Tumor Pathology · doi:10.1007/s10014-025-00505-3 · Cited by 4
Yuan, S., Zhu, W., Wang, Y., & Yu, L. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s539571 · Cited by 5
Sumii, M., Masuda, T., Shimoji, K., Yamaguchi, K., Sakamoto, S., Horimasu, Y., Mimae, T., Nakashima, T., Iwamoto, H., Miyata, Y., et al. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0890 · Cited by 4
AjTGFβ alleviates V. splendidus-induced inflammation through SMADs pathway in Apostichopus japonicus
Zhang, Z., wenwen, Y., Guanghui, H., Cheng-hua, L., & Lv, Z. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108593 · Cited by 4
Jeong, J., Kim, H., Park, S., Park, H., Jeong, M., Kwak, S., Sung, G., Song, J., Na, Y., & Choi, K. (2020) · Biology · doi:10.3390/biology9070143 · Cited by 4
Zhang, Y., Xu, W., Li, B.-Z., Lin, C.-Y., Cheng, Y.-X., Xiao, Y., Chen, D.-Y., Dong, W.-R., & Shu, M.-A. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.06.002 · Cited by 4
Li, X., Kaur, N., Albahrani, M., Karpf, A. R., Black, A. R., & Black, J. D. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.103017 · Cited by 4
Dynamics of transforming growth factor β signaling and therapeutic efficacy
Wu, S., Luwor, R. B., & Zhu, H. (2023) · Growth Factors · doi:10.1080/08977194.2023.2215335 · Cited by 5
Smad4-TGF-β Signaling Pathways in Pancreatic Cancer Pathogenesis
Korc, M. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_17 · Cited by 4
Ungefroren, H. (2006) · Signal Transduction · doi:10.1002/sita.200690034 · Cited by 4
miR302 regulates SNAI1 expression to control mesangial cell plasticity
Chiara, L. D., Andrews, D. C., Watson, A., Oliviero, G., Cagney, G., & Crean, J. K. G. (2017) · Scientific Reports · doi:10.1038/srep42407 · Cited by 3
Yadav, P., Kundu, P., Pandey, V. K., Amin, P. J., Nair, J., & Shankar, B. S. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2069299 · Cited by 3
Targeting Epithelial-to-Mesenchymal Transition for Breast Cancer Stem Cells Therapeutics
Suthakaran, S., Singh, D., Deshmukh, R. K., & Das, A. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_241 · Cited by 3
EMT Contributes to Chemoresistance in Pancreatic Cancer
Chava, S., Gayatri, M. B., & Reddy, A. B. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817661-0.00003-2 · Cited by 3
Cancer vaccines: The next generation
Knutson, K. L. (2005) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2005.11.002 · Cited by 3
Transforming Growth Factor-β (TGF-β) Signaling Inhibitors in Cancer Therapy
Datta, P. K., & Mann, J. R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_35 · Cited by 3
Self-citationPol, M., Gao, H., Fox, J. M., & Jia, X. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00007 · Cited by 3
Circulating Biomarkers and Targeted Therapy in Pleural Mesothelioma
Grant, C. R., Bazhenova, L. A., & Yun, K. M. (2025) · Cancers · doi:10.3390/cancers17233863 · Cited by 3
Zhang, Q., Chen, J., Zhou, L.-N., Wu, X.-F., Wu, Y.-Z., Li, W.-T., Xia, G.-Y., Xia, H., Shang, H.-C., Wei, X.-H., et al. (2025) · Pharmaceutical Biology · doi:10.1080/13880209.2025.2602234 · Cited by 2
Kou, Y.-L. N., Liu, Y.-J., Hsu, T.-C. N., Wu, K.-Y., Chen, S.-T., Chen, J. H., Lin, K.-Y., Wang, H.-H., Cheng, Y.-T., Chen, C., et al. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl45389 · Cited by 2
Loss of protein phosphatase 1 regulator TIMAP protein triggers EMT in A549 cells
Szalmás, F., Nagy, L., Bai, P., & Boratkó, A. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02873-5 · Cited by 2
Rastogi, S., Mishra, S. S., Singh, L., & Kumar, N. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202401981 · Cited by 2
The Role of Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Signaling in Cancer
Karfa, S., Saurav, S., Feng, B., Li, S., Law, B. K., & Datta, P. K. (2025) · Cells · doi:10.3390/cells14120854 · Cited by 2
Self-citationPancreatic Cancer: Current Concepts in Invasion and Metastasis
Chiblak, S., & Abdollahi, A. (2012) · InTech eBooks · doi:10.5772/28175 · Cited by 2
Rowley, D. R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_30 · Cited by 2
A Review of the Past, Present, and Future Directions of Neoplasia
Rehemtulla, A., & Ross, B. D. (2005) · Neoplasia · doi:10.1593/neo.05793 · Cited by 2
Targeting Epithelial-to-Mesenchymal Transition for Breast Cancer Stem Cells Therapeutics
Suthakaran, S., Singh, D., Deshmukh, R. K., & Das, A. (2021) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_241-1 · Cited by 1
Ferreira, R. S., Aires, H. I. R., Rebelo, C., Passos, J. F., Ori, A., Pitrez, P. R., & Ferreira, L. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124117 · Cited by 1
Yamamoto, S., Miyama, T., Komoda, T., SUGAWARA, M., Nonomura, M., & Nakanishi, J. (2019) · Analytical Sciences · doi:10.2116/analsci.19p233 · Cited by 1
Smad4/TGF-β Signaling Pathways in Pancreatic Cancer Pathogenesis
Norris, A. M., & Korc, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_17 · Cited by 1
Rastegar‐Pouyani, N., Farzin, M. A., Karimi, P., Jafarzadeh, E., Abdolvahab, M. H., & Najafi, M. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128320120240805104433 · Cited by 1
Azadian, Z., Shafiei, M., Hosseini, S., Kazemi, J., Alipour, A., & Shahsavarani, H. (2019) · COSMOS · doi:10.1142/s2591722619400064 · Cited by 1
Sedlmeier, G., Al‐Rawi, V., Buchert, J., Yserentant, K., Rothley, M., Steshina, A., Gräßle, S., Wu, R., Hurrle, T., Richer, W., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000065 · Cited by 1
Korc, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_32 · Cited by 1
Tumor Suppressor Functions of TGFβ1 in T Cells
Bommireddy, R., & Doetschman, T. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_23
Quality of CTL Therapies: A Changing Landscape
Thyagarajan, K., Chatterjee, S., Kesarwani, P., Nishimura, M. I., & Mehrotra, S. (2015) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-17807-3_14
Neoplasia: An Anniversary of Progress
Rehemtulla, A. (2007) · Neoplasia · doi:10.1593/neo.07968
Study of molecular mechanisms implicated in the TGF-beta oncogenic effect in Glioma
Juncà, A. G. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Selection of Clinically useful Angiogenesis-Related Biomarkers: An Update
Todorović‐Raković, N., Vujasinović, T., & Rabi, Z. A. (2012) · The International Journal of Biological Markers · doi:10.5301/jbm.2012.8989
epithelial cell line A549 epithelial-mesenchymal transition of human lung 1-induced
Ekekezie, I. I., Perez, R. E., Navarro, A., Rezaiekhaligh, M. H., & Mabry, S. M. (2016)
Temporal regulation of Pten is essential for retina regeneration in zebrafishPreprint
Gupta, S., Sharma, P., Chaudhary, M., Premraj, S., Kaur, S. J., Vijayan, V., & Ramachandran, R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.09.451767
Receptor protein serine/threonine kinase
(2009) · Springer eBooks · doi:10.1007/978-3-540-85701-3_14
Morsink, M. A. J., Koch, L. S., Hu, S., Weersma, R. K., van Goor, H., Bourgonje, A. R., & Broersen, K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.13.593851
Hippee, C. E., Durnell, L. A., Kaufman, J. W., Murray, E., Singh, B. K., & Sinn, P. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.12.603350
Tang, Y., Feng, Z., Ma, C., Jang, N., Chen, X., He, Y., Martin, F. L., Li, X., & Pang, W. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115574
Moskal, A., Myrczek, R., Wawro, M., Ruiz-Auladell, L., Baiges, A., Garcia, I., Gonzalez, F. M., Pujana, M. Á., Kochan, J. A., Hinz, A., et al. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.04.019
Roger, É., Mummey, H. M., Zimmer, E., Srinivasan, D., Härle, A., Moubri, L., Beutel, A. K., Singh, R., Ekizce, M., Melzer, M. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.16.676458
Novel mechanisms of cytokine signaling on T-cell and MDSC function in glioma development
Kohanbash, G. (2012) · D-Scholarship@Pitt (University of Pittsburgh)
Su, R., Zhang, Y., Cao, J., Chen, F., Li, X. B., Li, P., & Bian, G. (2025) · Research Square · doi:10.21203/rs.3.rs-7782471/v1
CD40 Stimulation Improves Osteogenesis from Mesenchymal Stem Cells via the Activation of TGF-β
Patra, S. K., Gurjar, D., Saha, B., & Lenka, N. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11077-w
Succinate activates fibroblasts through GPR91-HIF-1α-TGF-β1-Smad signaling
Zhang, Z., Wang, Z., Sun, H., Zhou, D., & Ma, W. (2026) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2026.102423
Polyploidy and Senescence of Cancer Cells: Impact of Cell Fusion
Bhattacharyya, S., Choudhury, D., Vedeshachaitanya, B., & Malakar, P. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-22637-2_10
Identification of TGF-β1 as a key regulator in DOX-induced cardiotoxicity
Mao, C., Zhang, Z. D., Xiao, D., He, J., Leng, X., Zhao, W., Zeng, M., Zhong, K., & Chen, Y. (2026) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-026-04419-9
CT radiomics for noninvasive prediction of histologic differentiation in gastric cancer
Su, R., Zhang, Y., Jf, C., Chen, F., Li, X. B., Li, P., & Bian, G. (2026) · Medical Physics · doi:10.1002/mp.70605
Artemisinin-derived radicals trigger TGFβ oxidation and degradation for alopecia therapy
Wang, R., Wang, C., Liu, C., Leong, H., Yan, Q., Zhang, Y., Liu, S., Li, Y., Wu, W., Wu, J., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124625
Sritharan, S., Jayavelu, T., & Sivalingam, N. (2026) · Medical Oncology · doi:10.1007/s12032-026-03404-5
Metadata
- Authors
- Halder, S. K., Beauchamp, R. D., & Datta, P. K.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Datta, Pran K.
- Venue
- Neoplasia
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 7
- Issue
- 5
- Pages
- 509-521
- ISSN
- 1476-5586 (ISSN-L)
- PMC
- PMC1501161
- OpenAlex
- W1990842005
- Cited by
- 288
- References
- 37
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 13 · 2023: 9 · 2022: 13 · 2021: 8 · 2020: 16 · 2019: 18 · 2018: 14 · 2017: 11 · 2016: 14 · 2015: 18 · 2014: 18 · 2013: 16 · 2012: 16
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neoplasia (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Cancer Research Institute
- GlaxoSmithKline
- Virginia Marine Resources Commission
- National Cancer Institute (R01CA095195, 5P50CA90949, R01CA95195, R01CA069457, CA-69457, P50CA090949)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK52334, R01DK052334)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- SB431542, TGF-beta, anticancer agents, epithelial-mesenchymal transition, tumor invasion, angiogenesis, metastasis, apoptosis, anchorage-independent growth, colony formation, cell motility, vascular endothelial growth factor, TGF-beta signaling
- MeSH terms
- Receptor, Transforming Growth Factor-beta Type I, Animals, Antineoplastic Agents, Benzamides, Cell Adhesion, Cell Line, Cell Movement, Dioxoles, Enzyme Inhibitors, Humans, Mink, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Neovascularization, Pathologic, Time Factors, Transcription, Genetic, Blotting, Western, Gene Expression Regulation, Neoplastic, Transforming Growth Factor beta, Apoptosis, Protein Serine-Threonine Kinases, Receptors, Transforming Growth Factor beta, Activin Receptors, Type I, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Immunoprecipitation, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review